Skip to main content

Targeted Formulations for Polycystic Ovary Syndrome

Clinical Focus AreasWHO-GMP
  • Insulin Sensitivity & Metabolic Support
  • Ovulatory Cycle Normalization
  • Oocyte Quality & Follicular Development
  • Hyperandrogenic Symptom Balance
Portfolio Count
03Formulations
Delivery Systems
01Formats (Tablets)
Validation Protocol
WHO-GMP & cGMP

Browse Formulations

3 Products
Scientific Rationale & Formulation Integrity
Synergistic stereoisomer ratios and insulin-sensitizing pathways engineered to restore metabolic and ovulatory equilibrium.

EUROZEN PHARMACEUTICAL QUALITY PILLAR • PCOS MANAGEMENT

PCOS is a multifaceted endocrine disorder. Our therapeutic approach incorporates synergistic combinations of Myo-Inositol, D-Chiro-Inositol, and vital co-factors to target root hormonal and metabolic dysfunctions.

WHO-GMP CertifiedStrict adherence to cGMP and validated pharmaceutical manufacturing norms.
Active BioavailabilityOptimized stereoisomers and chelated co-factors for cellular absorption.
Physician PrescribedFormulations engineered specifically for targeted clinical compliance.
Next Therapeutic Division

Nurturing Mother and Child Through Every Trimester